Virta Health is a telehealth provider clinically proven to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of drugs or surgery. At 1-year, 60% of patients in our clinical trial achieved diabetes reversal, 94% of insulin users reduced or eliminated usage altogether, and 83% of patients remained active in the trial. Results extended beyond diabetes reversal, with sustained improvements in blood pressure, inflammation, cardiovascular markers, insulin resistance and weight loss. Reversal is possible through individualized nutrition therapy focusing on carbohydrate restriction, personalized nutrition, daily biomarker monitoring (capturing blood glucose, blood ketones, weight, mood, energy) by a physician-led care team and behavior change. The Virta Treatment is monitored in almost real time through Virta’s fully virtual clinic with a continuous remote care technology platform, utilizing AI and ML, allowing for scalable, safe and sustainable physician oversight. As a covered entity, Virta interacts with patients through secure in-app messaging, telemedicine visits, and phone calls. Virta is a privately-held organization with over $300 million in VC Funding and a $2 billion valuation. Virta currently contracts with over 350 clients, including employers and health plans.